Amedisys earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) ...

The companies said they have an agreement to sell home health and hospice locations to BrightSpring Health Services and The ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

UnitedHealth Group CEO Andrew Witty has stepped down unexpectedly and company veteran Stephen Hemsley is returning to the top ...

Stephen Hemsley ran UnitedHealth Group for more than a decade. It's a different company after four years with Andrew Witty in ...

Andrew Witty, chief executive of UnitedHealth Group, has stepped down from his role for “personal reasons,” the company announced Tuesday. UnitedHealth also withdrew its financial forecast for 2025, ...

Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE ...

(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...